322 related articles for article (PubMed ID: 10480720)
1. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
McKerrow JH
Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
[TBL] [Abstract][Full Text] [Related]
2. Cysteine protease inhibitors as chemotherapy for parasitic infections.
McKerrow JH; Engel JC; Caffrey CR
Bioorg Med Chem; 1999 Apr; 7(4):639-44. PubMed ID: 10353643
[TBL] [Abstract][Full Text] [Related]
3. [Target points of antiparasitic drugs].
Boczoń K
Wiad Parazytol; 1988; 34(4-6):529-43. PubMed ID: 3071915
[No Abstract] [Full Text] [Related]
4. Drugs for parasitic infections.
Med Lett Drugs Ther; 1990 Mar; 32(814):23-32. PubMed ID: 2179697
[No Abstract] [Full Text] [Related]
5. Antiparasitic therapy.
Kappagoda S; Singh U; Blackburn BG
Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
[TBL] [Abstract][Full Text] [Related]
6. Development of protease inhibitors for protozoan infections.
McKerrow JH; Rosenthal PJ; Swenerton R; Doyle P
Curr Opin Infect Dis; 2008 Dec; 21(6):668-72. PubMed ID: 18978536
[TBL] [Abstract][Full Text] [Related]
7. The anti-parasitic effects of nitric oxide.
Ascenzi P; Bocedi A; Gradoni L
IUBMB Life; 2003; 55(10-11):573-8. PubMed ID: 14711001
[TBL] [Abstract][Full Text] [Related]
8. Drugs for parasitic infections.
Med Lett Drugs Ther; 1986 Jan; 28(706):9-16. PubMed ID: 3945225
[No Abstract] [Full Text] [Related]
9. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
[TBL] [Abstract][Full Text] [Related]
10. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents.
Massai L; Messori L; Micale N; Schirmeister T; Maes L; Fregona D; Cinellu MA; Gabbiani C
Biometals; 2017 Apr; 30(2):313-320. PubMed ID: 28283781
[TBL] [Abstract][Full Text] [Related]
11. Hoe 092 V, a new triazine derivative effective against a broad spectrum of fish and crustacean parasites.
Schmahl G; Raether W; Mehlhorn H
Parasitol Res; 1992; 78(8):702-6. PubMed ID: 1480610
[No Abstract] [Full Text] [Related]
12. [Treatment of diseases caused by parasites].
Pérez-Molina JA; Díaz-Menéndez M; Pérez-Ayala A; Ferrere F; Monje B; Norman F; López-Vélez R
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):44-59. PubMed ID: 20031280
[TBL] [Abstract][Full Text] [Related]
13. Old Antiprotozoal Drugs: Are They Still Viable Options for Parasitic Infections or New Options for Other Diseases?
Cortez-Maya S; Moreno-Herrera A; Palos I; Rivera G
Curr Med Chem; 2020; 27(32):5403-5428. PubMed ID: 31264538
[TBL] [Abstract][Full Text] [Related]
14. Antiparasitic effect of a fraction enriched in tight-binding protease inhibitors isolated from the Caribbean coral Plexaura homomalla.
Salas-Sarduy E; Cabrera-Muñoz A; Cauerhff A; González-González Y; Trejo SA; Chidichimo A; Chávez-Planes Mde L; Cazzulo JJ
Exp Parasitol; 2013 Nov; 135(3):611-22. PubMed ID: 24090569
[TBL] [Abstract][Full Text] [Related]
15. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
16. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
17. Cysteine proteinase inhibitors as therapy for parasitic diseases: advances in inhibitor design.
Steverding D; Caffrey CR; Sajid M
Mini Rev Med Chem; 2006 Sep; 6(9):1025-32. PubMed ID: 17018001
[TBL] [Abstract][Full Text] [Related]
18. [Nitric oxide and anti-protozoan chemotherapy].
Gradoni L; Ascenzi P
Parassitologia; 2004 Jun; 46(1-2):101-3. PubMed ID: 15305696
[TBL] [Abstract][Full Text] [Related]
19. Proteases of protozoan parasites.
Rosenthal PJ
Adv Parasitol; 1999; 43():105-59. PubMed ID: 10214691
[TBL] [Abstract][Full Text] [Related]
20. Scientific hypothesis: a new strategy for the design of anti-protozoal drugs--DNA polymerase as a drug target.
Biñas M; Johnson AM
Appl Parasitol; 1994 Sep; 35(3):157-68. PubMed ID: 7951392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
